Lurie Investment Fund

About The Fund

Lurie Investment Fund operates as the venture capital arm of the Ann and Robert H. Lurie Foundation, primarily focusing on innovation in the biomedical community. They are known for channeling investments into sectors such as medical devices, therapeutics, diagnostics, and services, as well as into cutting-edge fields like nanotechnology and MEMS (Micro-Electro-Mechanical Systems) technology. They target companies that have the potential to make significant contributions to medicine and healthcare, aiming to foster advancements that can lead to substantial improvements in patient outcomes and healthcare delivery. Lurie Investment Fund strategically allocates funds, setting a minimum investment threshold of $2,500,000 and capping their investments at $88,000,000, which allows them to participate in funding rounds with a significant impact while tailoring their contributions to the scale and needs of the ventures they support. Their investment philosophy centers on not just providing capital but also adding value through strategic guidance, leveraging their broad network and extensive expertise in the BioTech industry. This approach facilitates the growth and development of portfolio companies, empowering them to achieve scientific breakthroughs and commercial success. Although their primary aim is to generate substantial returns on investments, they also place a strong emphasis on catalyzing innovation and progress within the sectors they invest in, ultimately benefiting society through advancements in healthcare and medicine.